Viral infections directly involved in kidney allograft function

Area of Science:

• Nephrology
• Transplant Immunology
• Virology

Background:

• Immunosuppressive therapy improves kidney transplant outcomes but increases infectious complication risks.
• Viruses like adenovirus and polyomavirus BK (BKV) can cause significant kidney graft dysfunction.

Purpose of the Study:

• To review the clinical impact of viral infections, specifically adenovirus and BKV, in kidney transplant recipients.
• To discuss current diagnostic and treatment strategies for viral nephropathy post-transplant.
• To highlight unresolved issues and future directions in managing BKV-associated nephropathy.

Main Methods:

• Review of clinical manifestations and pathological findings associated with adenovirus and BKV infections.
• Analysis of current treatment approaches, including immunosuppression reduction and adjunct therapies.
• Discussion of diagnostic challenges and the need for improved classification systems (e.g., Banff Working Group).

Main Results:

• Adenovirus infections typically cause symptomatic hemorrhagic cystitis and tubulointerstitial nephritis, often reversible.
• BKV infection can lead to asymptomatic but severe nephropathy with poor graft outcomes, especially when tissue-invasive.
• Current treatment focuses on reducing immunosuppression, with ongoing trials for adjunct therapies.

Conclusions:

• Viral infections remain a critical challenge in kidney transplantation, impacting long-term graft survival.
• Effective management of BKV-associated nephropathy requires further research into diagnosis, treatment, and prevention.
• Development of vaccines and novel drugs is crucial for preventing and treating BKV nephropathy.